SALIOGEN THERAPEUTICS
SalioGen Therapeutics is a gene coding company that develops potentially curative therapies for patients with inherited disorders. Its Gene Coding approach is guided by our Exact DNA Integration Technology (EDIT) platform, a genome engineering technology that leverages proprietary mammal-derived enzymes they call Saliogase. With broad applicability, non-viral delivery capabilities of any size gene, and significant manufacturing advantages, EDIT has the potential to transform the treatment paradigm for inherited disorders and beyond.
SALIOGEN THERAPEUTICS
Industry:
Biotechnology Genetics Life Science Therapeutics
Founded:
2020-01-01
Address:
Burlington, Massachusetts, United States
Country:
United States
Website Url:
http://www.saliogen.com
Total Employee:
11+
Status:
Active
Contact:
(650) 906-9468
Total Funding:
135 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins Global Site Tag
Similar Organizations
Affinia Therapeutics
Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with devastating diseases.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Parthenon Therapeutics
Parthenon Therapeutics is a biotech company inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment.
Ray Therapeutics
Ray Therapeutics is a biotech company developing optogenetic gene therapies for patients with blinding diseases.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Board_member
Board_member
2021-12-01
Current Employees Featured
Joseph Higgins President & Chief Scientific Officer, Founder @ SalioGen Therapeutics
President & Chief Scientific Officer, Founder
Sung You Chief Business and Strategy Officer @ SalioGen Therapeutics
Chief Business and Strategy Officer
2021-07-01
Ray Tabibiazar Chairman & CEO @ SalioGen Therapeutics
Chairman & CEO
2021-01-01
Founder
Investors List
SymBiosis LLC
SymBiosis LLC investment in Series B - SalioGen Therapeutics
D1 Capital Partners
D1 Capital Partners investment in Series B - SalioGen Therapeutics
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Series B - SalioGen Therapeutics
Retinal Degeneration Fund
Retinal Degeneration Fund investment in Series B - SalioGen Therapeutics
GordonMD Global Investments
GordonMD Global Investments investment in Series B - SalioGen Therapeutics
Cystic Fibrosis Foundation
Cystic Fibrosis Foundation investment in Series B - SalioGen Therapeutics
T. Rowe Price
T. Rowe Price investment in Series B - SalioGen Therapeutics
EPIQ Capital Group
EPIQ Capital Group investment in Series B - SalioGen Therapeutics
PBM Capital Group
PBM Capital Group investment in Series A - SalioGen Therapeutics
Official Site Inspections
http://www.saliogen.com
- Host name: 172.67.217.228
- IP address: 172.67.217.228
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Saliogen.com lookup results from whois.cloudflare.com server:
- Domain created: 17th-Oct-2019
- Domain updated: 24th-Mar-2024
- Domain expires: 17th-Oct-2027 2 Years, 115 Days left
- Website age: 5 Years, 250 Days
- Registrar Domain ID: 2444558790_DOMAIN_COM-VRSN
- Registrar Url: http://www.cloudflare.com
- Registrar WHOIS Server: whois.cloudflare.com
- Registrar Abuse Contact Email: registrar-abuse@cloudflare.com
- Registrar Abuse Contact Phone: +1.6503198930
- Name server:
- ALDO.NS.CLOUDFLARE.COM
- MICHELLE.NS.CLOUDFLARE.COM
More informations about "SalioGen Therapeutics"
SalioGen Therapeutics - Crunchbase Company Profile …
SalioGen Therapeutics is a gene coding company that develops potentially curative therapies for patients with inherited disorders. Its Gene Coding …See details»
SalioGen Therapeutics
The Company is no longer operating. Any questions may be submitted by email to: Saliogen@vlpc.com. Correspondence can also be sent to: SalioGen Therapeutics 124 …See details»
SalioGen Therapeutics - Overview, News & Similar companies
SalioGen Therapeutics Announces Selection of Development Candidate for ABCA4-mediated Stargardt Disease--SGT-1001 is the first development candidate using SalioGen's novel Gene …See details»
SalioGen Therapeutics | LinkedIn
SalioGen Therapeutics | 3,256 followers on LinkedIn. Accelerating the impact of genetic medicines for patients with Gene Coding™ technology | SalioGen Therapeutics is a …See details»
SalioGen Therapeutics - Craft
SalioGen Therapeutics is a company developing genetic medicine for patients with inherited disorders. It uses a genetic modification approach that works by adding a new genomic code …See details»
Saliogen Therapeutics - Products, Competitors, Financials, …
Saliogen Therapeutics is a biotechnology company focused on advancing genetic medicine through its innovative Gene Coding technology. The company's main offerings include non …See details»
SalioGen Therapeutics Strengthens its Leadership Team to
Jul 20, 2022 SalioGen is focused on developing therapies for more patients with inherited diseases that are beyond what is addressable with current technologies, initially focusing on …See details»
SalioGen Therapeutics 2025 Company Profile: …
SalioGen Therapeutics is headquartered in Foxboro, MA. What is the size of SalioGen Therapeutics? SalioGen Therapeutics has 75 total employees. What industry is SalioGen Therapeutics in? SalioGen Therapeutics’s primary …See details»
SalioGen Therapeutics hit by layoffs, as gene-editing …
Oct 13, 2024 SalioGen Therapeutics, a company that raised $135 million to develop a new gene-editing technology, has instituted widespread layoffs and is scaling back its ambitions.See details»
SalioGen Therapeutics Overview | SignalHire Company Profile
SalioGen Therapeutics is a biotechnology company on a mission to accelerate the impact of genetic medicine for patients using its novel Gene Coding™ technology. Gene Coding is a non …See details»
SalioGen Therapeutics - Contacts, Employees, Board Members
SalioGen Therapeutics is a gene coding company that develops potentially curative therapies for patients with inherited disorders. ... Experience the new Crunchbase, powered by AI . …See details»
SalioGen Therapeutics Closes $115 Million Oversubscribed Series B ...
Jan 5, 2022 SalioGen is focused on developing therapies for more patients with inherited diseases that are beyond what is addressable with current technologies, initially focusing on …See details»
SalioGen Therapeutics Closes $115 Million Oversubscribed
Jan 5, 2022 SalioGen Therapeutics investors@saliogen.com. Media Contact: Amy Jobe, Ph.D. LifeSci Communications 315-879-8192 ajobe@lifescicomms.com. GordonMD Global …See details»
VCs plow $115M into next-gen genetic medicine startup SalioGen, …
Jan 5, 2022 SalioGen Therapeutics is moving quickly. Ten months after exiting stealth with $20 million in series A funds, the Massachusetts-based biotech has raised another $115 million to …See details»
SalioGen Therapeutics Announces Closing of $20 Million Series A ...
Introducing a mammal-derived genome engineering enzyme for next-generation gene and cell therapy Financing to fund SalioGen’s pipeline in genetic diseases, based on proprietary EDIT …See details»
SalioGen Therapeutics - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name ... Money Raised . Lead Investors . Jan 5, 2022: Series B - SalioGen Therapeutics . 8: …See details»
How SalioGen’s attempt to turn ‘jumping genes’ into medicines …
May 2, 2025 SalioGen Therapeutics, led by Ray Tabibiazar, shut down after failing to perfect its bat-derived gene editing technology. Despite raising $115M, the company struggled with …See details»
SalioGen Therapeutics Strengthens Management with Key
Jul 28, 2021 SalioGen Therapeutics is advancing Gene Coding to develop durable, broadly applicable genetic medicines, initially using its Exact DNA Integration Technology (EDIT) …See details»
SalioGen Therapeutics Announces Closing of $20 Million
Mar 1, 2021 SalioGen is initially focused on providing durable, safe and affordable non-viral gene therapy to more patients with inherited diseases that are beyond what is addressable …See details»
SalioGen Therapeutics - Tech Stack, Apps, Patents & Trademarks
Organization. SalioGen Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 5. ...See details»